Table 2.

Treatment characteristics (N = 11).

Patient	Intent	Total dose (Gy)	Fractions	Clinical target volumes	Concurrent chemotherapy
1	Definitive	70	33	Local recurrence + bilateral neck LN	No
2	Definitive	70	35	Local recurrence + comprehensive left neck LN	No
3	Definitive	70	35	Local recurrence	No
4	Definitive	70	33	Local recurrence + bilateral neck LN	No
5	Definitive	66	30	Local recurrence + bilateral neck LN	No
6	Definitive	66	30	Local recurrence + bilateral neck LN	No
7	Definitive	60	30	Comprehensive left neck	No
8	Definitive	70	35	Comprehensive bilateral neck LN	No
9	Definitive	70	35	Local recurrence + bilateral neck LN	No
10	Adjuvant	66	33	Comprehensive bilateral neck LN	No
11	Adjuvant	66	30	Local recurrence + bilateral neck LN	No

Abbreviation: LN, lymph node.